MUCOSAL HEALING WITH VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: EVIDENCE FROM EARNEST, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN CHRONIC POUCHITIS

Vipul Jairath  1     Brian G. Feagan  2     Mark S. Silverberg  3     Silvio Danese  4     Paolo Gionchetti  5     Mark Lowenberg  6     Brian Bressler  7     Marc Ferrante  8     Ailsa L Hart  9     Dirk Lindner  10     Armella Escher  10     Stephen Jones  10     Bo Shen  11     Simon Travis  12    
1 Western University, London, Canada
2 Alimentiv Inc., London, Canada
3 Mount Sinai Hospital, Toronto, Canada
4 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy
5 IRCCS Azienda Ospedaliera-Universitaria di Bologna University of Bologna, Bologna, Italy
6 Amsterdam University Medical Center, Amsterdam, Netherlands
7 University of British Columbia, Vancouver, Canada
8 University Hospitals Leuven, Leuven, Belgium
9 St Mark’s Hospital and and Imperial College London, London, United Kingdom
10 Takeda Pharmaceuticals International AG, Zurich, Switzerland
11 Columbia University Irving Medical Center/Herbert Irving Pavilion, New York, United States
12 John Radcliffe Hospital, Oxford, United Kingdom

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing